In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a 2-((2,3-Dimethylphenyl)amino)benzoic acid Drug Master File in Korea (2-((2,3-Dimethylphenyl)amino)benzoic acid KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of 2-((2,3-Dimethylphenyl)amino)benzoic acid. The MFDS reviews the 2-((2,3-Dimethylphenyl)amino)benzoic acid KDMF as part of the drug registration process and uses the information provided in the 2-((2,3-Dimethylphenyl)amino)benzoic acid KDMF to evaluate the safety and efficacy of the drug.
After submitting a 2-((2,3-Dimethylphenyl)amino)benzoic acid KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their 2-((2,3-Dimethylphenyl)amino)benzoic acid API can apply through the Korea Drug Master File (KDMF).
click here to find a list of 2-((2,3-Dimethylphenyl)amino)benzoic acid suppliers with KDMF on PharmaCompass.